Publications

Partnership for Safe Medicines urges FDA advisory committee to reject compounding of unapproved peptides The Partnership for Safe Medicines (PSM) has formally submitted comments to the U.S. Food and Drug Administration (FDA) Pharmacy Compounding Advisory Committee (PCAC), strongly opposing the addition of seven bulk peptide drug substances to the Section ...

Peptide therapies - popular, unproven, dangerous Peptides are short-chain amino acids used in approved medicines like insulin and GLP-1s, but also in a wide variety of substances that haven't been clinically studied or reviewed by regulators. They have gained online popularity for unproven claims around things like anti-aging, healing and ...

Publication: Weight loss promotions are out of hand on social media, and it's endangering patients The internet is overrun with content promoting injectable weight loss medicines and there's no way for viewers to know whether what they're seeing is legitimate, genuine, safe, or true. Policymakers, social media platforms, and individuals ...

Publication: A call to action: Restoring and strengthening America's patient safety system; protecting patients from the risks of mass drug compounding PMS's June 2026 report outlines solutions to protect patient safety in the growing compounded GLP-1 marketplace. A Call to Action: Restoring and Strengthening America's Patient Safety System serves as ...

Prescription Drug Freight Fraud, June 2026 report Over the past year, our freight fraud investigations have documented a rapidly evolving pipeline of pharmaceutical imports tied to increasing demand for weight loss and wellness drugs. In previous reports, we identified kilogram-scale shipments of semaglutide and tirzepatide entering the United States from ...

Prescription drug freight fraud, April 2026 Over the last six months, freight fraud involving GLP-1 drugs was persistent and adaptive. Semaglutide and tirzepatide shippers evolved tactics to obscure origins, contents, and manufacturing sources. We observed familiar risks, unregistered facilities, residential "manufacturers," and expanding code fraud.   Read the report and ...

What is master carton smuggling? In March, customs officers in Cincinnati announced that they had intercepted around 5,000 individual shipments of GLP-1s and other peptides packaged inside more than 300 "master cartons" with deceptive manifests meant to slip by inspections unnoticed. Curious how this smuggling scheme works? Read on, and ...

Using pharmacy-to-pharmacy marketplaces? Read this Suspicious Sales Surveillance Report March 24, 2026 Online pharmacy-to-pharmacy marketplaces help pharmacies with inventory management, but they also carry a higher risk of being exploited by criminals selling black market medicines that are a threat to American patients. Because of that, pharmacies who use these ...

Update on drug importation, February 2026 For over 25 years, well-meaning advocates have proposed importing unauthenticated medicine from foreign countries' drug supplies to lower prices for Americans. Past efforts didn't pay off financially and raised public health risks, but legislatures continue to consider state importation schemes while individual employers are ...

Prescription drug freight fraud report, January 2026 In November and December 2025, thousands of shipments of drugs that have been popularized by social media were imported into the United States, along with rivaroxaban (Xarelto) and antibiotics. They were imported into the country with a wide range of product code classifications, ...